Not Yet RecruitingNCT06820723
This study is comparing CYB003 with placebo for people with Depression or Anxiety. Participants receive CYB003 or placebo and complete study visits and assessments.
DepressionDrugFrom 21 Years to 65 Years
- Countries
- United States
- Sponsor
- Ohio State University
- Condition
- Depression
Not Yet RecruitingNCT06689787
This study is looking at whether a digital support tool can help people with Psychosocial Functioning, Stress Disorders, Post-Traumatic, or major depression. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Depression
Active Not RecruitingNCT04201106
This study is comparing Open Label Placebo with Rationale with placebo for people with Depression. Participants receive Open Label Placebo with Rationale or placebo and complete study visits and assessments.
DepressionBehavioralFrom 13 Years to 18 Years
- Countries
- United States
- Sponsor
- University of California, San Francisco
- Condition
- Depression
RecruitingNCT06188923
This observational study is following people with Anxiety and Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Depression
RecruitingNCT07390331
This study is looking at care and outcomes for people with Depression and CVD. Taking part may give some people access to psychoeducation, but direct benefit is not guaranteed.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Columbia University
- Condition
- Depression
RecruitingNCT07115329
This study is comparing Zelquistinel with placebo for people with depression. Participants receive Zelquistinel or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Syndeio Biosciences, Inc
- Condition
- Depression
Active Not RecruitingNCT06941844
This study is comparing Placebo with placebo for people with depression. Participants receive Placebo or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- United States
- Sponsor
- Definium Therapeutics US, Inc.
- Condition
- Depression
Not Yet RecruitingNCT03833206
This study is looking at evaluate the safety and the effective doses of PDC-1421 in cancer patients with depression. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionOtherFrom 21 Years to 85 Years
- Countries
- United States
- Sponsor
- BioLite, Inc.
- Condition
- Depression
Active Not RecruitingNCT05733546
This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionDrugOver 18 Years
- Countries
- United States
- Sponsor
- COMPASS Pathways
- Condition
- Depression
RecruitingNCT05081596
This study is looking at whether a digital support tool can help people with Depression, Pain, or Cognitive Impairment. Participants take part in a digital support tool and complete follow-up assessments.
DepressionOtherOver 60 Years
- Countries
- United States
- Sponsor
- Weill Medical College of Cornell University
- Condition
- Depression
RecruitingNCT03887715
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- LivaNova
- Condition
- Depression
RecruitingNCT06906939
This study is looking at whether a digital support tool can help people with Knee Osteoarthritis or Depression. Participants take part in a digital support tool and complete follow-up assessments.
DepressionOtherFrom 50 Years to 95 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Depression
RecruitingNCT06775379
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 74 Years
- Countries
- United States
- Sponsor
- Xenon Pharmaceuticals Inc.
- Condition
- Depression
RecruitingNCT07076407
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Finland, Poland, Romania, Slovakia, United States
- Sponsor
- Xenon Pharmaceuticals Inc.
- Condition
- Depression
Not Yet RecruitingNCT07227103
This study is looking at whether ONE-D TMS can help people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionDrugFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
- Condition
- Depression
CompletedNCT05841030
This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
Active Not RecruitingNCT03642964
This study is comparing CTC-501 with placebo for people with depression. Participants receive CTC-501 or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Chase Therapeutics Corporation
- Condition
- Depression
TerminatedNCT05518149
This study is looking at whether Aticaprant can help people with major depression. Participants take part in Aticaprant and complete follow-up assessments.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
RecruitingNCT07412756
This study is comparing Brenipatide with placebo for people with major depression. Participants receive Brenipatide or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
- Sponsor
- Eli Lilly and Company
- Condition
- Depression
RecruitingNCT05803551
This study is looking at care and outcomes for people with Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionDrugFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Depression
RecruitingNCT06793397
This study is testing whether CYB003, compared with placebo, is safe and helpful as an add-on treatment for people with depression. Participants receive CYB003 or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 85 Years
- Countries
- Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
- Sponsor
- Cybin IRL Limited
- Condition
- Depression
RecruitingNCT07186309
This observational study is following people with Postpartum Depression or Pregnancy to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionDeviceOver 18 Years
- Countries
- United States
- Sponsor
- University of Virginia
- Condition
- Depression
RecruitingNCT06254612
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Sirtsei Pharmaceuticals, Inc.
- Condition
- Depression
Not Yet RecruitingNCT06710431
This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionDrugFrom 21 Years to 65 Years
- Countries
- United States
- Sponsor
- Afasci Inc
- Condition
- Depression
RecruitingNCT07276997
This study is comparing Icalcaprant with placebo for people with depression. Participants receive Icalcaprant or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Depression